Glucagon-like peptide 1 and glucose-dependent insulinotropic peptide hormones and novel receptor agonists protect synapses in Alzheimer’s and Parkinson’s diseases
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.